Used in research settings to quantify asymmetric dimethylarginine (ADMA) levels in mouse biological samples such as plasma, serum, or tissue homogenates. ADMA is an endogenous inhibitor of nitric oxide synthase, making it a key biomarker for endothelial dysfunction and cardiovascular diseases. This ELISA kit enables scientists to study the role of ADMA in animal models of hypertension, atherosclerosis, diabetes, and kidney disease. It supports high-throughput, accurate measurement essential for preclinical studies and drug development targeting nitric oxide pathways.